Speaker illustration

Professor Sang-Hyun Kim

Boramae Hospital, Seoul (Korea (Republic of))

Member of:

European Society of Cardiology
Heart Failure Association

Professor Kim's research focuses on the management of dyslipidemia and other risk factors to prevent cardiovascular disease. He is especially interested in evaluation of traditional and new risk factors and their attributable risks in Asian people. He participated in the process of Asian treatment guideline with the emphasis on treatment gap and patient compliance for the dyslipidemia management.

New clinical outcomes of Fimasartan

Event: ESC Congress 2022

Topic: Hypertension

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb